Idexx Laboratories | IDXX - Gross Profit On Sales


Idexx Laboratories reported $779.09M in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
Abbott USD 6.65B 787M Jun/2026
Accuray USD 41.89M 7.42M Dec/2024
Align Technology USD 757.43M 20.84M Jun/2026
AngioDynamics USD 44.78M 2.93M Sep/2025
Dentsply International USD 493M 66M Jun/2026
Dexcom USD 750.3M 42.4M Mar/2026
Edwards Lifesciences USD 1.35B 62.6M Jun/2026
Fujifilm JPY 376.67B 29.16B Mar/2026
Globus Medical USD 548.17M 51.91M Jun/2026
Henry Schein USD 1.03B 39M Jun/2026
Idexx Laboratories USD 779.09M 56.35M Jun/2026
Inogen USD 41.34M 1.39M Sep/2024
Insulet USD 562.6M 21.8M Jun/2026
Integra LifeSciences USD 215.97M 2.77M Jun/2026
Intuitive Surgical USD 2.02B 193.4M Jun/2026
Neogen USD 105.5M 2.3M Jun/2026
Orthofix International USD 153.28M 4.76M Dec/2025
Phibro Animal Health USD 133.5M 12.6M Dec/2025
ResMed USD 861.22M 29.76M Jun/2026
Roche Holding CHF 22.69B 600M Jun/2026
Steris USD 684.2M 12.9M Jun/2026
Tandem Diabetes Care USD 144.78M 7.99M Jun/2026
Teleflex USD 331.71M 24.28M Jun/2026
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Zoetis USD 1.76B 140M Jun/2026